MLAB Mesa Laboratories Inc

Price (delayed)

$146.39

Market cap

$778.4M

P/E Ratio

N/A

Dividend/share

$0.64

EPS

-$0.29

Enterprise value

$951.24M

Mesa Labs is a global leader in the design and manufacturing of critical quality control solutions for the pharmaceutical, healthcare, medical device, industrial safety, environmental, and food and beverage industries. ...

Highlights
MLAB's revenue is up by 44% year-on-year and by 8% since the previous quarter
The gross profit has grown by 33% YoY and by 8% from the previous quarter
The company's quick ratio has shrunk by 78% YoY but it rose by 3.2% QoQ
Mesa Laboratories's net income has shrunk by 183% QoQ and by 139% YoY
The company's EPS has shrunk by 181% QoQ and by 136% YoY

Key stats

What are the main financial stats of MLAB
Market
Shares outstanding
5.32M
Market cap
$778.4M
Enterprise value
$951.24M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
2.03
Price to sales (P/S)
3.86
EV/EBIT
1,147.45
EV/EBITDA
32.29
EV/Sales
4.76
Earnings
Revenue
$199.87M
EBIT
$829,000
EBITDA
$29.46M
Free cash flow
$22.82M
Per share
EPS
-$0.29
Free cash flow per share
$4.33
Book value per share
$72.22
Revenue per share
$37.9
TBVPS
$31.72
Balance sheet
Total assets
$685.81M
Total liabilities
$305.38M
Debt
$216.59M
Equity
$380.43M
Working capital
$84M
Liquidity
Debt to equity
0.57
Current ratio
2.9
Quick ratio
1.94
Net debt/EBITDA
5.87
Margins
EBITDA margin
14.7%
Gross margin
59.1%
Net margin
-0.8%
Operating margin
-1.5%
Efficiency
Return on assets
-0.2%
Return on equity
-0.4%
Return on invested capital
0.3%
Return on capital employed
0.1%
Return on sales
0.4%
Dividend
Dividend yield
0.44%
DPS
$0.64
Payout ratio
N/A

MLAB stock price

How has the Mesa Laboratories stock price performed over time
Intraday
1.65%
1 week
4.88%
1 month
-10.72%
1 year
-51.12%
YTD
-55.38%
QTD
3.95%

Financial performance

How have Mesa Laboratories's revenue and profit performed over time
Revenue
$199.87M
Gross profit
$118.22M
Operating income
-$3.02M
Net income
-$1.56M
Gross margin
59.1%
Net margin
-0.8%
Mesa Laboratories's net income has shrunk by 183% QoQ and by 139% YoY
The net margin has plunged by 180% from the previous quarter and by 128% YoY
MLAB's operating income has plunged by 164% from the previous quarter and by 125% YoY
The operating margin has plunged by 158% from the previous quarter and by 117% YoY

Growth

What is Mesa Laboratories's growth rate over time

Valuation

What is Mesa Laboratories stock price valuation
P/E
N/A
P/B
2.03
P/S
3.86
EV/EBIT
1,147.45
EV/EBITDA
32.29
EV/Sales
4.76
The company's EPS has shrunk by 181% QoQ and by 136% YoY
MLAB's price to book (P/B) is 58% less than its 5-year quarterly average of 4.8 and 44% less than its last 4 quarters average of 3.6
MLAB's equity is down by 4.7% year-on-year and by 3.4% since the previous quarter
The P/S is 55% below the 5-year quarterly average of 8.5 and 55% below the last 4 quarters average of 8.5
MLAB's revenue is up by 44% year-on-year and by 8% since the previous quarter

Efficiency

How efficient is Mesa Laboratories business performance
MLAB's return on equity has dropped by 180% since the previous quarter and by 140% year-on-year
The return on assets has dropped by 167% since the previous quarter and by 129% year-on-year
Mesa Laboratories's return on invested capital has shrunk by 94% YoY and by 90% QoQ
The company's return on sales has shrunk by 94% YoY and by 90% QoQ

Dividends

What is MLAB's dividend history
DPS
$0.64
Dividend yield
0.44%
Payout ratio
N/A
Recent dividends

Financial health

How did Mesa Laboratories financials performed over time
Mesa Laboratories's total assets is 125% more than its total liabilities
The company's quick ratio has shrunk by 78% YoY but it rose by 3.2% QoQ
MLAB's current ratio has dropped by 69% year-on-year but it is up by 12% since the previous quarter
The debt is 43% less than the equity
MLAB's debt to equity is up by 36% YoY and by 3.6% QoQ
The debt has grown by 28% YoY

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.